Ola Hansson

Dr. Ola Hansson

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
EAEmma Ahlqvist
Emma Ahlqvist
PSPetter Storm
Petter Storm
AKAnnemari Käräjämäki
Annemari Käräjämäki
MMMats Martinell
Mats Martinell
MDMozhgan Dorkhan
Mozhgan Dorkhan
LGLeif Groop
Leif Groop

13 May 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AMAlisa K Manning
Alisa K Manning
MHMarie-France Hivert
Marie-France Hivert
RSRobert A Scott
Robert A Scott
JGJonna L Grimsby
Jonna L Grimsby
NBNabila Bouatia-Naji
Nabila Bouatia-Naji
CLClaudia Langenberg
Claudia Langenberg

8 September 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JFJoão Fadista
João Fadista
PVPetter Vikman
Petter Vikman
ELEmilia Ottosson Laakso
Emilia Ottosson Laakso
IMInês Mollet
Inês Mollet
Jonathan EsguerraJonathan Esguerra
Jonathan Esguerra
LGLeif Groop
Leif Groop
Significance: We provide a comprehensive catalog of novel genetic variants influencing gene expression and metabolic phenotypes in human pancreatic islets. The data also show that the path from genetic variation (SNP) to gene expression is more complex than hitherto often assumed, and that we need to consider that genetic variation can also influence function of a gene by influencing exon usage or splice isoforms (sQTL), allelic imbalance, RNA editing, and expression of noncoding RNAs, which in turn can influence expression of target genes.

15 November 2012 in Diabetes
Verified
Journal Article
Open access
PDF file
Marloes Dekker NitertMarloes Dekker Nitert
Marloes Dekker Nitert
TDTasnim Dayeh
Tasnim Dayeh
PVPeter Volkov
Peter Volkov
TETarg Elgzyri
Targ Elgzyri
EHElin Hall
Elin Hall
CLCharlotte Ling
Charlotte Ling
To identify epigenetic patterns, which may predispose to type 2 diabetes (T2D) due to a family history (FH) of the disease, we analyzed DNA methylation genome-wide in skeletal muscle from individuals with (FH+) or without (FH−) an FH of T2D. We found differential DNA methylation of genes in biological pathways including mitogen-activated protein kinase (MAPK), insulin, and calcium signaling (P ≤ 0.007) and of individual genes with known function in muscle, including MAPK1, MYO18B, HOXC6, and the AMP-activated protein kinase subunit PRKAB1 in skeletal muscle of FH+ compared with FH− men. We further validated our findings from FH+ men in monozygotic twin pairs discordant for T2D, and 40% of 65 analyzed genes exhibited differential DNA methylation in muscle of both FH+ men and diabetic twins. We further examined if a 6-month exercise intervention modifies the genome-wide DNA methylation pattern in skeletal muscle of the FH+ and FH− individuals. DNA methylation of genes in retinol metabolism and calcium signaling pathways (P < 3 × 10−6) and with known functions in muscle and T2D including MEF2A, RUNX1, NDUFC2, and THADA decreased after exercise. Methylation of these human promoter regions suppressed reporter gene expression in vitro. In addition, both expression and methylation of several genes, i.e., ADIPOR1, BDKRB2, and TRIB1, changed after exercise. These findings provide new insights into how genetic background and environment can alter the human epigenome.

1 July 2012 in Cell Metabolism
Verified
Journal Article
Closed access
JTJalal Taneera
Jalal Taneera
SLStefan Lang
Stefan Lang
ASAmitabh Sharma
Amitabh Sharma
JFJoao Fadista
Joao Fadista
YZYuedan Zhou
Yuedan Zhou
LGLeif Groop
Leif Groop

8 January 2010 in Science
Verified
Journal Article
Closed access
PDF file
ARAnders H. Rosengren
Anders H. Rosengren
RJRamunas Jokubka
Ramunas Jokubka
DTDamon Tojjar
Damon Tojjar
CGCharlotte Granhall
Charlotte Granhall
OHOla Hansson
Ola Hansson
ERErik Renström
Erik Renström
Ratting Out a Diabetes Gene: Inbred animals with inherited susceptibility to disease can be especially informative regarding pathogenetic mechanisms because they carry naturally occurring genetic variants of the same type that cause disease in humans. This principle is illustrated byRosengrenet al.(p.217; published online 19 November), whose analysis of an inbred strain of rats prone to develop type 2 diabetes led to the discovery of a gene whose aberrant overexpression suppresses pancreatic insulin secretion in both rats and humans. The culprit gene, ADRA2A, encodes the alpha2A adrenergic receptor and is potentially a valuable lead for diabetes therapy because it can be targeted pharmacologically.